NCT01542710

Bimatoprost/Timolol Versus Travoprost/Timolol

Bimatoprost/Timolol Versus Travoprost/Timolol Fixed Combinations in an Egyptian Population: A Hospital-Based Prospective Randomized Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Kasr El Aini Hospital · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare 2 fixed combination medications in intraocular pressure lowering.

Detailed description

PURPOSE: To compare the efficacy of bimatoprost/timolol (BTFC) or travoprost/timolol (TTFC) fixed combinations on intraocular pressure (IOP) reduction in an Egyptian population. METHODS: Patients with primary open angle glaucoma (POAG) were randomized to receive either BTFC or TTFC. IOPs were measured at baseline, 2 weeks, and 1, 2, 4, and 6 months. The primary outcome measures were the mean change in IOP from baseline

Conditions

• Glaucoma

Interventions

Type	Name	Description
DRUG	Ganfort	Bimatoprost/Timolol fixed combination
DRUG	Duotrav	Fixed combination of Travoprost and Timolol

Timeline

• Start date: 2011-01-01
• Primary completion: 2011-12-01
• Completion: 2011-12-01
• First posted: 2012-03-02
• Last updated: 2012-03-02

Locations

1 site across 1 country: Egypt